Development, validation and clinical use of the dynamic pruritus score (DPS) - PruDPS

niversitätsklinikum Münster0 个研究点目标入组 157 人开始时间: 2014年4月15日最近更新: 2024年8月19日

试验速览

暂无简介。

•Age >18, male and female, out- and in-patients with atopic dermatitis, urticaria, prurigo nodularis and chronic pruritus.
•The patients received a topical therapy (between V1 and V2) during the study for 2 weeks.

•Age below 18 years, pregnancy, breastfeeding, active psychosomatic and psychiatric disorders, known active malignant underlying diseases, previous studies within the last 4 weeks, drug use, drug abuse, topical application of tacrolimus, pimecrolimus, polidocanol, menthol, cannabinoid agonists or capsaicin within the last 2 weeks prior to the study, systemic administration of steroids, cyclosporine A and other immunosuppressive agents, naltrexone, UV therapy within the last two weeks before the study start, systemic administration of antihistamines, topical steroids within one week prior to the study, acute exacerbation or cutaneous infections in atopic dermatitis

发起方

niversitätsklinikum Münster